Economic and practical challenges to the formulation of vaccines against endemic infectious diseases such as malaria

Methods

Volumn 40, Issue 1, 2006, Pages 77-85

  Plebanski, Magdalena ^a   Lopez, Ester ^a   Proudfoot, Owen ^a   Cooke, Brian M ^b   Von Itzstein, Mark ^c   Coppel, Ross L ^b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Economic; Infectious diseases; Malaria; Vaccine

Indexed keywords

4 AMINOQUINOLINE; 8 AMINOQUINOLINE DERIVATIVE; BCG VACCINE; CHLOROQUINE; LIPOSOME; MALARIA VACCINE; MEFLOQUINE; MEPACRINE; MICROSPHERE; PAMAQUINE; POLYGLACTIN; RECOMBINANT PROTEIN; SMALLPOX VACCINE; VIROSOME;

AFRICA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG SAFETY; ENDEMIC DISEASE; HUMAN; IMMUNIZATION; INFANT MORTALITY; MALARIA; MICROENCAPSULATION; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SMALLPOX; TUBERCULOSIS; UNITED STATES; VACCINATION; WORLD HEALTH ORGANIZATION;

CHEMISTRY, PHARMACEUTICAL; COMMUNICABLE DISEASE CONTROL; MALARIA VACCINES; VACCINES;

EID: 33748782834     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2006.05.021     Document Type: Article

References (40)

1. Geenough P. Soc. Sci. Med. 41 (1995) 1973-1975
2. Davis M.M., Zimmerman J.L., Wheeler J.R., and Freed G.L. Am. J. Public Health 92 (2002) 1982-1987
3. S. Siwolop, in: New York Times, vol. Late Edition, Section C, page 1, Column 2, 2001.
4. J. Milstien, B. Candries, 2002, Economics of vaccine development and implementation: changes over the Past 20 Years. .
5. D. DeRock, 2001, Immunization financing in developing countries and the international vaccine market. .
6. World Biotech Supplement 4, 1999.
7. FDA. URL. .
8. Supakankunti S., Janjaroen W.S., Tangphao O., Ratanawijitrasin S., Kraipornsak P., and Pradithavanij P. Bull. World Health Organ. 79 (2001) 461-470
9. S. Venu, The Ipr effect on drug prices. .
10. J. Milstien, S. Glass, A. Batson, M. Greco, J. Berger, 2001. Divergence of vaccine product lines in industrialized and developing countries, paper presented to the Strategic Advisory Group of Experts of the World Health Organization's Department of Vaccines and Biologicals.
11. URL. .
12. Andre F.E., and Foulkes M.A. Dev. Biol. Stand. 95 (1998) 57-60
13. Milstien J., and Batson A. Drug Inf. J. 32 (1998) 175
14. Esparza J., and Bhamarapravati N. Lancet 355 (2000) 2061-2066
15. M. Cropper, M. Haile, J. Lampietti, C. Poulos, D. Whittington, 2000, World Bank, p. 2273.
16. M. Cropper, M. Haile, J. Lampietti, C. Poulos, D. Whittington, 2002. The Demand for a Malaria Vaccine: Evidence from Ethiopia.
17. Chima R.I., Goodman C.A., and Mills A. Health Policy 63 (2003) 17-36
18. S. Foster, 1991. in: Bull. World Health Organ, p. 349.
19. Snow R.W., Trape J.F., and Marsh K. Trends Parasitol. 17 (2001) 593-597
20. P.B. Bloland, 2001. URL: .
21. Foster S., and Phillips M. Ann. Trop. Med. Parasitol. 92 (1998) 391-398
22. Alonso P.L., Sacarlal J., Aponte J.J., Leach A., Macete E., Aide P., Sigauque B., Milman J., Mandomando I., Bassat Q., Guinovart C., Espasa M., Corachan S., Lievens M., Navia M.M., Dubois M.C., Menendez C., Dubovsky F., Cohen J., Thompson R., and Ballou W.R. Lancet 366 (2005) 2012-2018
23. Reece W.H., Pinder M., Gothard P.K., Milligan P., Bojang K., Doherty T., Plebanski M., Akinwunmi P., Everaere S., Watkins K.R., Voss G., Tornieporth N., Alloueche A., Greenwood B.M., Kester K.E., McAdam K.P., Cohen J., and Hill A.V. Nat. Med. 10 (2004) 406-410
24. Bongartz M., Rezbach P., Borrmann S., Hollingdale M.R., Kremsner P.G., and Luty A.J. Parasitol. Res. 88 (2002) 1083-1089
25. Stoute J.A., Slaoui M., Heppner D.G., Momin P., Kester K.E., Desmons P., Wellde B.T., Garcon N., Krzych U., and Marchand M. N. Engl. J. Med. 336 (1997) 86-91
26. Stoute J.A., Kester K.E., Krzych U., Wellde B.T., Hall T., White K., Glenn G., Ockenhouse C.F., Garcon N., Schwenk R., Lanar D.E., Sun P., Momin P., Wirtz R.A., Golenda C., Slaoui M., Wortmann G., Holland C., Dowler M., Cohen J., and Ballou W.R. J. Infect. Dis. 178 (1998) 1139-1144
27. Lalvani A., Moris P., Voss G., Pathan A.A., Kester K.E., Brookes R., Lee E., Koutsoukos M., Plebanski M., Delchambre M., Flanagan K.L., Carton C., Slaoui M., Van Hoecke C., Ballou W.R., Hill A.V., and Cohen J. J. Infect. Dis. 180 (1999) 1656-1664
28. Fifis T., Gamvrellis A., Crimeen-Irwin B., Pietersz G.A., Li J., Mottram P.L., McKenzie I.F., and Plebanski M. J. Immunol. 173 (2004) 3148-3154
29. Carcaboso A.M., Hernandez R.M., Igartua M., Rosas J.E., Patarroyo M.E., and Pedraz J.L. Pharm. Res. 21 (2004) 121-126
30. Oliveira G.A., Wetzel K., Calvo-Calle J.M., Nussenzweig R., Schmidt A., Birkett A., Dubovsky F., Tierney E., Gleiter C.H., Boehmer G., Luty A.J., Ramharter M., Thornton G.B., Kremsner P.G., and Nardin E.H. Infect. Immun. 73 (2005) 3587-3597
31. Hill A.V. Nat. Rev. Immunol. 6 (2006) 21-32
32. Galazka A., and Wysokinska T. Postepy. Hig. Med. Dosw. 52 (1998) 157-172
33. Walther M., Dunachie S., Keating S., Vuola J.M., Berthoud T., Schmidt A., Maier C., Andrews L., Andersen R.F., Gilbert S., Poulton I., Webster D., Dubovsky F., Tierney E., Sarpotdar P., Correa S., Huntcooke A., Butcher G., Williams J., Sinden R.E., Thornton G.B., and Hill A.V. Vaccine 23 (2005) 857-864
34. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Wetzel K., Maier C., Birkett A.J., Sarpotdar P., Corado M.L., Thornton G.B., and Schmidt A. Infect. Immun. 72 (2004) 6519-6527
35. Poltl-Frank F., Zurbriggen R., Helg A., Stuart F., Robinson J., Gluck R., and Pluschke G. Clin. Exp. Immunol. 117 (1999) 496-503
36. Pfeiffer B., Peduzzi E., Moehle K., Zurbriggen R., Gluck R., Pluschke G., and Robinson J.A. Angew. Chem. Int. Ed. Engl. 42 (2003) 2368-2371
37. Mueller M.S., Renard A., Boato F., Vogel D., Naegeli M., Zurbriggen R., Robinson J.A., and Pluschke G. Infect. Immun. 71 (2003) 4749-4758
38. Rosas J.E., Pedraz J.L., Hernandez R.M., Gascon A.R., Igartua M., Guzman F., Rodriguez R., Cortes J., and Patarroyo M.E. Vaccine 20 (2002) 1707-1710
39. Rosas J.E., Hernandez R.M., Gascon A.R., Igartua M., Guzman F., Patarroyo M.E., and Pedraz J.L. Vaccine 19 (2001) 4445-4451
40. Fries L.F., Gordon D.M., Richards R.L., Egan J.E., Hollingdale M.R., Gross M., Silverman C., and Alving C.R. Proc. Natl. Acad. Sci. USA 89 (1992) 358-362